AN EARLY COST-EFFECTIVENESS ANALYSIS OF XEVINAPANT IN COMBINATION WITH CHEMO-RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK IN UNITED STATES-MedSci.cn

AN EARLY COST-EFFECTIVENESS ANALYSIS OF XEVINAPANT IN COMBINATION WITH CHEMO-RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK IN UNITED STATES

Gandola, A; Ait, SR; Orfanos, P; Bouisset, F; Licitra, L

VALUE IN HEALTH, 2021; 24 (): S32

科室
- - 订阅+
  - 更多科室
工具
服务